Dose-Finding Clinical Trial to Evaluate the Efficacy and Safety of LV232 Capsules in the Treatment of MDD

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-finding Phase II clinical trial aimed to determine the optimal dose of LV232 capsules for treating MDD, evaluate preliminary efficacy and safety, and provide a basis for Phase III trial design and dosing regimen determination.
Epistemonikos ID: 9b0cee6f1b573d308981a714017a9d4248cdb737
First added on: Mar 01, 2025